July 11, 2024 02:59 PM EDT
Pharma
FDA+

Sen­ate unan­i­mous­ly pass­es bi­par­ti­san phar­ma patent bill

Zachary Brennan

Senior Editor

The Sen­ate in a unan­i­mous vote Thurs­day af­ter­noon passed a bill that aims to tack­le phar­ma­ceu­ti­cal patent abus­es by lim­it­ing the num­ber of patents that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PARP biotech backed by more than five phar­mas clos­es af­ter nine years

23andMe board re­jects Anne Wo­j­ci­c­ki’s take-pri­vate plan, re­quests changes

Short­age of Lil­ly's block­buster GLP-1 drugs is over, ac­cord­ing to FDA

Mass­a­chu­setts' plan for $1B in life sci­ence in­vest­ment stalls in state leg­is­la­ture

In Japan, sales of Ei­sai and Bio­gen's Alzheimer's drug be­gin to ac­cel­er­ate

sponsored

Hy­brid Clin­i­cal Tri­als: Chang­ing the dy­nam­ic and build­ing a more ef­fi­cient tri­al ecosys­tem.

A service from the Financial Times